This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Hydroxycut Caffeine-Free Rapid Release Caplets

Starting date:
May 1, 2009
Posting date:
January 18, 2010
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-2010A21

Recalled products

  1. Hydroxycut Caffeine-Free Rapid Release Caplets

Reason

Iovate initiated a voluntary recall of 11 Hydroxycut products sold on the Canadian market as a result of FDA's assessment of 23 AD reports of liver related problems. On May 01, 2009, the Food and Drug Administration has issued an advisory urging consumers to discontinue the use of Hydroxycut products.

Depth of distribution

Distributed to retail level through wholesalers and distributors. Iovate does not export these products.

Affected products

Hydroxycut Caffeine-Free Rapid Release Caplets

DIN, NPN, DIN-HIM
No Market Authorization
Dosage form
  • Caplets
Strength
  • Not Applicable
Lot or serial number
  • All lots
Companies
Recalling Firm
Iovate Health Sciences Inc.
381 North Service Road West
Oakville
L6M 0H4
Ontario
CANADA
Marketing Authorization Holder
Iovate Health Sciences Inc.
381 North Service Road West
Oakville
L6M 0H4
Ontario
CANADA

Date modified: